Characterization of humoral and cellular immune responses in cynomolgus macaques upon primary and subsequent heterologous infections with dengue viruses

Microbes and Infection

Volumn 9, Issue 8, 2007, Pages 940-946

  Koraka, Penelopie ^a   Benton, Sabrina ^b   Amerongen, Geert van ^a   Stittelaar, Koert J ^a,b   Osterhaus, Albert D M E ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ViroClinics Biosciences BV   (Netherlands)

Author keywords

Cynomolgus macaque; Dengue virus; Sequential infections

Indexed keywords

CYTOKINE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; MACACA; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION; T LYMPHOCYTE; VIREMIA; VIRUS PATHOGENESIS;

ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOCYTE ACTIVATION; MACACA FASCICULARIS; SEROTYPING; T-LYMPHOCYTES; VIRAL NONSTRUCTURAL PROTEINS; VIREMIA;

ANIMALIA; DENGUE VIRUS; DENGUE VIRUS GROUP; MACACA;

EID: 34250354283     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.03.012     Document Type: Article

References (30)

1. Selin L.K., Varga S.M., Wong I.C., and Welsh R.M. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T-cell populations. J. Exp. Med. 188 (1998) 1705-1715
2. Chen H.D., Fraire A.E., Joris I., Brehm M.A., Welsh R.M., and Selin L.K. Memory CD8+T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2 (2001) 1067-1076
3. Sabin A.B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1 (1952) 30-50
4. Vaughn D.W. Invited commentary: Dengue lessons from Cuba. Am. J. Epidemiol. 152 (2000) 800-803
5. Halstead S.B. Immune enhancement of viral infection. Prog. Allergy. 31 (1982) 301-364
6. Mathew A., Kurane I., Rothman A.L., Zeng L.L., Brinton M.A., and Ennis F.A. Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a. J. Clin. Invest. 98 (1996) 1684-1691
7. Bashyam H.S., Green S., and Rothman A.L. Dengue virus-reactive CD8+T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J. Immunol. 176 (2006) 2817-2824
8. Mangada M.M., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Libraty D.H., Green S., Ennis F.A., and Rothman A.L. Dengue-specific T-cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J. Infect. Dis. 185 (2002) 1697-1703
9. Mathew A., Kurane I., Green S., Vaughn D.W., Kalayanarooj S., Suntayakorn S., Ennis F.A., and Rothman A.L. Impaired T-cell proliferation in acute dengue infection. J. Immunol. 162 (1999) 5609-5615
10. Mathew A., Kurane I., Green S., Stephens H.A., Vaughn D.W., Kalayanarooj S., Suntayakorn S., Chandanayingyong D., Ennis F.A., and Rothman A.L. Predominance of HLA-restricted cytotoxic T-lymphocyte responses to serotype-cross-reactive epitopes on nonstructural proteins following natural secondary dengue virus infection. J. Virol. 72 (1998) 3999-4004
11. Russell P.K., Nisalak A., Sukhavachana P., and Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J. Immunol. 99 (1967) 285-290
12. Callahan J.D., Wu S.J., on-Schultz A., Mangold B.E., Peruski L.F., Watts D.M., Porter K.R., Murphy G.R., Suharyono W., King C.C., Hayes C.G., and Temenak J.J. Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus. J. Clin. Microbiol. 39 (2001) 4119-4124
13. Groen J., Koraka P., Velzing J., Copra C., and Osterhaus A.D. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin. Diagn. Lab. Immunol. 7 (2000) 867-871
14. Kurane I., Zeng L., Brinton M.A., and Ennis F.A. Definition of an epitope on NS3 recognized by human CD4+ cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4. Virology 240 (1998) 169-174
15. Gagnon S.J., Zeng W., Kurane I., and Ennis F.A. Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones. J. Virol. 70 (1996) 141-147
16. Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., and Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181 (2000) 2-9
17. Innis B.L. Antibody responses to dengue virus infection. In: Gubler D.J., and Kuno G. (Eds). Dengue and Dengue Hemorrhagic Fever (1997), CAB International, New York 221-243
18. World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control (1997), WHO, Geneva
19. Mongkolsapaya J., Dejnirattisai W., Xu X.N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., Sawasdivorn S., Duangchinda T., Dong T., Rowland-Jones S., Yenchitsomanus P.T., McMichael A., Malasit P., and Screaton G. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9 (2003) 921-927
20. Halstead S.B., and O'Rourke E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146 (1977) 201-217
21. Halstead S.B., and O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265 (1977) 739-741
22. Roehrig J.T. Antigenic structure of flavivirus proteins. Adv. Virus Res. 59 (2003) 141-175
23. Rothman A.L. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 60 (2003) 397-419
24. Halstead S.B., Rojanasuphot S., and Sangkawibha N. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg. 32 (1983) 154-156
25. Papaevangelou G., and Halstead S.B. Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic?. J. Trop. Med. Hyg. 80 (1977) 46-51
26. Tadano M., Okuno Y., Fukunaga T., and Fukai K. Retrospective serological studies on dengue epidemics in Osaka and Okinawa. Biken. J. 26 (1983) 165-167
27. Green S., Kurane I., Pincus S., Paoletti E., and Ennis F.A. Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones. Virology 234 (1997) 383-386
28. Chaturvedi U.C., Elbishbishi E.A., Agarwal R., Raghupathy R., Nagar R., Tandon R., Pacsa A.S., Younis O.I., and Azizieh F. Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J. Med. Virol. 59 (1999) 335-340
29. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B.L., Kurane I., Rothman A.L., and Ennis F.A. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179 (1999) 755-762
30. Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Rothman A.L., and Ennis F.A. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J. Med. Virol. 59 (1999) 329-334